Literature DB >> 12761492

Differential regulation of SOCS genes in normal and transformed erythroid cells.

Mohinder K Sarna1, Evan Ingley, Samantha J Busfield, Vanessa S Cull, Winald Lepere, David J McCarthy, Michael J Wright, Gene A Palmer, David Chappell, Melissa S Sayer, Warren S Alexander, Douglas J Hilton, Robyn Starr, Stephanie S Watowich, Thomas Bittorf, S Peter Klinken, Peta A Tilbrook.   

Abstract

The SOCS family of genes are negative regulators of cytokine signalling with SOCS-1 displaying tumor suppressor activity. SOCS-1, CIS and SOCS-3 have been implicated in the regulation of red blood cell production. In this study, a detailed examination was conducted on the expression patterns of these three SOCS family members in normal erythroid progenitors and a panel of erythroleukemic cell lines. Unexpectedly, differences in SOCS gene expression were observed during maturation of normal red cell progenitors, viz changes to CIS were inversely related to the alterations of SOCS-1 and SOCS-3. Similarly, these SOCS genes were differentially expressed in transformed erythoid cells - erythroleukemic cells immortalized at an immature stage of differentiation expressed SOCS-1 and SOCS-3 mRNA constitutively, whereas in more mature cell lines SOCS-1 and CIS were induced only after exposure to erythropoietin (Epo). Significantly, when ectopic expression of the tyrosine kinase Lyn was used to promote differentiation of immature cell lines, constitutive expression of SOCS-1 and SOCS-3 was completely suppressed. Modulation of intracellular signalling via mutated Epo receptors in mature erythroleukemic lines also highlighted different responses by the three SOCS family members. Close scrutiny of SOCS-1 revealed that, despite large increases in mRNA levels, the activity of the promoter did not alter after erythropoietin stimulation; in addition, erythroid cells from SOCS-1-/- mice displayed increased sensitivity to Epo. These observations indicate complex, stage-specific regulation of SOCS genes during normal erythroid maturation and in erythroleukemic cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12761492      PMCID: PMC2396148          DOI: 10.1038/sj.onc.1206381

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  66 in total

Review 1.  The molecular mechanism of erythropoietin action.

Authors:  M J Koury; M C Bondurant
Journal:  Eur J Biochem       Date:  1992-12-15

2.  Dominant action of mutated erythropoietin receptors on differentiation in vitro and erythroleukemia development in vivo.

Authors:  V Cull; P A Tilbrook; A S Adenan; D Chappell; E Ingley; M K Sarna; T N Palmer; S S Watowich; S P Klinken
Journal:  Oncogene       Date:  2000-02-17       Impact factor: 9.867

3.  Evolution of a mutant J2E erythroid cell line which does not respond to erythropoietin.

Authors:  S P Klinken; N A Nicola
Journal:  Leukemia       Date:  1990-01       Impact factor: 11.528

4.  Twenty proteins containing a C-terminal SOCS box form five structural classes.

Authors:  D J Hilton; R T Richardson; W S Alexander; E M Viney; T A Willson; N S Sprigg; R Starr; S E Nicholson; D Metcalf; N A Nicola
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-06       Impact factor: 11.205

5.  SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine.

Authors:  W S Alexander; R Starr; J E Fenner; C L Scott; E Handman; N S Sprigg; J E Corbin; A L Cornish; R Darwiche; C M Owczarek; T W Kay; N A Nicola; P J Hertzog; D Metcalf; D J Hilton
Journal:  Cell       Date:  1999-09-03       Impact factor: 41.582

6.  Aberrant hematopoiesis in mice with inactivation of the gene encoding SOCS-1.

Authors:  D Metcalf; W S Alexander; A G Elefanty; N A Nicola; D J Hilton; R Starr; S Mifsud; L Di Rago
Journal:  Leukemia       Date:  1999-06       Impact factor: 11.528

7.  Changes in c-Kit expression and effects of SCF during differentiation of human erythroid progenitor cells.

Authors:  N Uoshima; M Ozawa; S Kimura; K Tanaka; K Wada; Y Kobayashi; M Kondo
Journal:  Br J Haematol       Date:  1995-09       Impact factor: 6.998

Review 8.  Cytokine receptor signalling.

Authors:  J N Ihle
Journal:  Nature       Date:  1995-10-19       Impact factor: 49.962

9.  Separation of myeloid and erythroid progenitors based on expression of CD34 and c-kit.

Authors:  M O De Jong; G Wagemaker; A W Wognum
Journal:  Blood       Date:  1995-12-01       Impact factor: 22.113

10.  A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors.

Authors:  A Yoshimura; T Ohkubo; T Kiguchi; N A Jenkins; D J Gilbert; N G Copeland; T Hara; A Miyajima
Journal:  EMBO J       Date:  1995-06-15       Impact factor: 11.598

View more
  10 in total

1.  Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways.

Authors:  Wei Tong; Jing Zhang; Harvey F Lodish
Journal:  Blood       Date:  2005-02-10       Impact factor: 22.113

2.  DYRK3 dual-specificity kinase attenuates erythropoiesis during anemia.

Authors:  Olga Bogacheva; Oleg Bogachev; Madhu Menon; Arvind Dev; Estelle Houde; Elizabeth I Valoret; Haydn M Prosser; Caretha L Creasy; Susan J Pickering; Evelyn Grau; Kim Rance; George P Livi; Vinit Karur; Connie L Erickson-Miller; Don M Wojchowski
Journal:  J Biol Chem       Date:  2008-10-14       Impact factor: 5.157

3.  Hepatocellular heme oxygenase-1: a potential mechanism of erythropoietin-mediated protection after liver ischemia-reperfusion injury.

Authors:  Kimberly J Riehle; Vicki Hoagland; Whitney Benz; Jean S Campbell; Denny H Liggitt; Lorrie A Langdale
Journal:  Shock       Date:  2014-11       Impact factor: 3.454

4.  Identification of contact sites between ankyrin and band 3 in the human erythrocyte membrane.

Authors:  Jesse L Grey; Gayani C Kodippili; Katya Simon; Philip S Low
Journal:  Biochemistry       Date:  2012-08-14       Impact factor: 3.162

5.  Loss of JAK2 regulation via a heterodimeric VHL-SOCS1 E3 ubiquitin ligase underlies Chuvash polycythemia.

Authors:  Ryan C Russell; Roxana I Sufan; Bing Zhou; Pardeep Heir; Severa Bunda; Stephanie S Sybingco; Samantha N Greer; Olga Roche; Samuel A Heathcote; Vinca W K Chow; Lukasz M Boba; Terri D Richmond; Michele M Hickey; Dwayne L Barber; David A Cheresh; M Celeste Simon; Meredith S Irwin; William Y Kim; Michael Ohh
Journal:  Nat Med       Date:  2011-06-19       Impact factor: 53.440

6.  Division of labor by dual feedback regulators controls JAK2/STAT5 signaling over broad ligand range.

Authors:  Julie Bachmann; Andreas Raue; Marcel Schilling; Martin E Böhm; Clemens Kreutz; Daniel Kaschek; Hauke Busch; Norbert Gretz; Wolf D Lehmann; Jens Timmer; Ursula Klingmüller
Journal:  Mol Syst Biol       Date:  2011-07-19       Impact factor: 11.429

7.  Dynamic ligand modulation of EPO receptor pools, and dysregulation by polycythemia-associated EPOR alleles.

Authors:  Seema Singh; Rakesh Verma; Anamika Pradeep; Karen Leu; R Bruce Mortensen; Peter R Young; Miho Oyasu; Peter J Schatz; Jennifer M Green; Don M Wojchowski
Journal:  PLoS One       Date:  2012-01-12       Impact factor: 3.240

8.  Direct targets of pSTAT5 signalling in erythropoiesis.

Authors:  Kevin R Gillinder; Hugh Tuckey; Charles C Bell; Graham W Magor; Stephen Huang; Melissa D Ilsley; Andrew C Perkins
Journal:  PLoS One       Date:  2017-07-21       Impact factor: 3.240

9.  Promotion of Erythropoietic Differentiation in Hematopoietic Stem Cells by SOCS3 Knock-Down.

Authors:  Yu-xiao Liu; Xing Dong; Feng Gong; Ning Su; Su-bo Li; Hai-tao Zhang; Jia-ling Liu; Jing-hui Xue; Shou-ping Ji; Zhi-wen Zhang
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

10.  MiR-124-3p/B4GALT1 axis plays an important role in SOCS3-regulated growth and chemo-sensitivity of CML.

Authors:  Yu-Xiao Liu; Li Wang; Wen-Jia Liu; Hai-Tao Zhang; Jing-Hui Xue; Zhi-Wen Zhang; Chun-Ji Gao
Journal:  J Hematol Oncol       Date:  2016-08-12       Impact factor: 17.388

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.